Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Browse by Current Cardiff authors

Number of items: 4.

Collins, Jemima T., Noble, Simon ORCID:, Chester, John ORCID:, Davies, Helen E., Evans, William D. ORCID:, Farewell, Daniel ORCID:, Lester, Jason F., Parry, Diane, Pettit, Rebecca and Byrne, Anthony 2018. The value of physical performance measurements alongside assessment of sarcopenia in predicting receipt and completion of planned treatment in non-small cell lung cancer: an observational exploratory study. Supportive Care in Cancer 26 , pp. 119-127. 10.1007/s00520-017-3821-6

Lester, Jason F, Casbard, Angela C ORCID:, Al-Taei, Saly, Harrop, Richard, Katona, Lajos ORCID:, Attanoos, Richard L, Tabi, Zsuzsanna and Griffiths, Gareth O 2018. A single centre phase II trial to assess the immunological activity of TroVax® plus pemetrexed/cisplatin in patients with malignant pleural mesothelioma - the SKOPOS trial. OncoImmunology 7 (12) , e1457597. 10.1080/2162402X.2018.1457597

Jones, Robert J., Crabb, S. J., Chester, John D. ORCID:, Elliott, T., Huddart, R. A., Birtie, A. J., Evans, L., Lester, Jason Francis, Huang, Chao, Casbard, Angela ORCID:, Madden, Tracie-Ann ORCID: and Griffiths, Gareth 2016. TOUCAN: A randomised phase II trial of carboplatin and gemcitabine plus /- vandetanib in first line treatment of advanced urothelial cell cancer in patients who are not suitable to receive cisplatin [Abstract]. American Journal of Clinical Oncology 34 (S25) , 448.

Lester, Jason F., Evans, Lauren Marie, Yousef, Zaheer R., Penney, A., Brown, Paul and Perks, Richard ORCID: 2014. A national audit of current cardiac device policies from radiotherapy centres across the UK. Clinical Oncology 26 (1) , pp. 45-50. 10.1016/j.clon.2013.09.004

This list was generated on Sun Jun 4 04:56:20 2023 BST.